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TubulinERK1 and ERK2 are highly homologous isoforms that often play redundant roles in regulating cellular functions.
We analyzed the spatiotemporal patterns of ERK1 and ERK2 in resting and activated mast cells. Strikingly, we
identiﬁed distinct pathways for these kinases. ERK1 localized to the cytosol and translocated to the nucleus
upon cell activation and kinase phosphorylation. In contrast, ERK2 distributed between the cytosol and near
the microtubule organizing center (MTOC) in resting cells and accumulated further at a pericentrosomal region
upon cell trigger. Pericentrosomal accumulation of ERK2 was phosphorylation independent, required an intact
microtubule network and was signiﬁcantly enhanced by the overexpression of Neuronal Calcium Sensor-1
(NCS-1). We also identiﬁed γ-tubulin and phosphatidylinositol 4 kinaseβ (PI4Kβ), a downstream effector of
NCS-1, as novel partner proteins of ERK2. Taken together, our results imply non-redundant functions of ERK1
and ERK2 in mast cells and implicate NCS-1 and PΙ4Κβ as regulators of ERK2 trafﬁcking.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The extra-cellular regulated kinases ERK1 and ERK2 comprise a
subfamily of the mitogen-activated protein kinases (MAPKs) that
transduce signals for fundamental cellular processes, including prolifer-
ation, survival and differentiation (reviewed in [1]). ERK1/2 compart-
mentalize to distinct organelles, including the nucleus, mitochondria,
endosomes and theGolgi apparatus (reviewed in [2]). This spatial distri-
bution links ERK1/2 signals with the regulation of the respective or-
ganelle activities (reviewed in [2]). Previously, we have noted such
compartmentalization in mast cells [3]. The latter are secretory cells of
the immune system that are best known for their involvement in allergic
reactions, but do also play important protective roles in host defense
mechanisms against pathogens and envenomation [4,5], as well as in
wound healing [6]. Both protective and pathological activities are medi-
ated by external cue-stimulated release of inﬂammatory mediators,
part of which are pre-stored in secretory granules (e.g. histamine andERC, endocytic recycling com-
1, Neuronal Calcium Sensor-1;
+972 3 640 7432.
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l rights reserved.proteases) and released within minutes, while others are formed de
novo (e.g. arachidonic acid metabolites and multiple cytokines) and
released within a couple of hours [7–10]. Mast cell stimuli include aller-
gens and their speciﬁc immunoglobulin E (IgE) antibodies, whose
sequential binding to the FcεRI promotes cell activation, as well as mul-
tiple soluble ligands, pathogens and interactions with neighboring cells
[11–15].
ERK1/2 have been implicated in mediating both early and late
responses of activated mast cells [16–18]. We noticed that in FcεRI-
triggered cells, ERK(s) are distributed between the nucleus and a
perinuclear location, which we have identiﬁed as the endocytic
recycling compartment (ERC) [3], a microtubule organizing center
(MTOC) associated organelle, involved in slow recycling and polarized
trafﬁcking [19,20]. ERK targeting to the ERC was increased by the phos-
phatidylinositol 4 kinaseβ (PI4Kβ) and its upstream activator, Neuronal
Calcium Sensor-1 (NCS-1), and correlated with increased recycling [3].
In the present work, we sought to investigate the mechanism underly-
ing ERK(s) translocation to the ERC. Surprisingly, we found that the
ERK1 and ERK2 isoforms segregate in activated mast cells, whereby
ERK1 follows the canonical pathway translocating to the nucleus,
whereas ERK2 pursues a non-canonical pathway that involves its asso-
ciation with the MTOC and subsequent accumulation at the ERC. Our
ﬁndings thus add to the recently accumulating data demonstrating
divergent functions of ERK1 and ERK2.
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Fig. 1. ERK1 and ERK2 expression in RBL cells. RBL cell extracts (50 μg/lane) were sep-
arated by SDS-PAGE and analyzed byWestern blot using polyclonal antibodies directed
against ERK1/2, ERK1 and ERK2, as indicated.
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2.1. Antibodies
Polyclonal anti-total ERK1/2 and monoclonal DNP-speciﬁc IgE
(SPE-7) antibodies were purchased from Sigma-Aldrich Chemicals
Co (St. Louis, MO). Polyclonal anti-total ERK1 antibody was purchased
from Abcam (Cambridge, MA). Polyclonal anti-total ERK2, mono-
clonal anti-α-tubulin and monoclonal anti-γ-tubulin antibodies wereAg 
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5
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Fig. 2. Cellular localization of ERK1 and ERK2 in RBL cells. IgE sensitized RBL cells, grown on gla
(antigen, Ag) for 5 min as described under Materials andmethods. The cells were either directly
ation (A, indicated and B–E). Cells were then labeledwith rabbit polyclonal antibodies against ER
andCy2 or Cy5-conjugateddonkey anti-mouse IgG. Cellswere visualized by high-resolution lase
3 separate experiments are presented. The enlargements in B correspond to the boxed areas. Qu
5–9 cells is shown in C and was calculated by the Imaris software; open columns correspond to
with α-tubulin. The results presented are Means± SEM. 3D reconstruction of acquired Z-stack
mitotic cells is depicted in E. Arrowheads point to theMTOCand thearrow inE points to themidbpurchased from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal
anti-PI4Kβ antibody was purchased from Upstate (Billerica, MA).
HRP-conjugated goat anti-mouse and goat anti-rabbit IgGs, Cy3 and
Cy2-conjogated goat anti-mouse or anti-rabbit IgGs, and Cy3 and Cy5-
conjugated donkey anti-mouse or anti-rabbit IgGs were purchased
from Jackson ImmunoResearch Laboratories (West Grove, PA).
2.2. Reagents
The protease inhibitor cocktail Complete was obtained from Roche
Diagnostics (Indianapolis, IN). DNP-human serum albumin (HSA), glu-
tathione sepharose, digitonin, DNP-HSA and nocodazole were obtained
from Sigma-Aldrich Chemicals Co (St. Louis, MO). U0126 was obtained
from A.G. Scientiﬁc (San Diego, CA). EGF was from Cyto-lab (Murrells
Inlet, SC).
2.3. DNA constructs
GST-PI4Kβ-full length and NCS-1 cDNA were a generous gift from
Dr. Andreas Jeromin (Banyan Biomarkers, Inc., Alachua, Florida, United
States of America).
2.4. Cell culture
RBL-2H3 cells (herein referred to as RBL)weremaintained in adher-
ent cultures in Dulbecco's Modiﬁed Eagle's Medium (DMEM) supple-
mented with 10% FBS in a humidiﬁed atmosphere of 5% CO2 at 37 °C.
HeLa, Cos7 and HEK293 cells were grown in DMEM supplementedERK2 
ERK2 
ERK2 
ss cover slips, were either left untreated (time zero) or activated with 50 ng/ml DNP-HSA
ﬁxedwith 4% PFA or gently permeabilized with 100 μg/ml digitonin for 5 min prior to ﬁx
K1 or ERK2, orα-tubulin, as indicated, followed by Cy3-conjugated donkey anti-rabbit IgG
r confocalmicroscopy, as described underMaterials andmethods. Representative images o
antiﬁcation of the extent of colocalization between ERK2 andMTOC-localizedα-tubulin in
the colocalization of α-tubulin with ERK2 and ﬁlled columns to the colocalization of ERK2
ed images was performed by the Imaris software and is shown in D. ERK2 localization in
ody. Phase images are shown and the circled areas in B depict the sites of ERK2 localization-
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Fig. 2 (continued).
2072 A.B. Bar-Gill et al. / Biochimica et Biophysica Acta 1833 (2013) 2070–2082with high glucosewith 10% FBS in a humidiﬁed atmosphere of 5% CO2 at
37 °C.
2.5. Cell transfection
RBL cells (8 × 106)were transfectedwith 20 μgof either recombinant
vector (pcDNA3-NCS-1) or empty pcDNA3 vector by electroporation
(250 V, 960 μF). Cells were immediately replated in tissue culture dishescontaining growth medium (supplemented DMEM). G-418 (1 mg/ml)
was added 24 h after transfection and stable transfectants were selected
within 14 days.
2.6. Stimulation of RBL cells
RBL cells were plated in 24-well plates (2 × 105 cells/well) and in-
cubated for 2 h in a humidiﬁed incubator at 37 °C with a monoclonal
E30
ERK2 merge α-tubulin
Fig. 2 (continued).
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in Tyrode buffer (10 mM HEPES, pH 7.4, 130 mM NaCl, 5 mM KCl,
1.4 mM CaCl2, 1 mMMgCl2, 5.6 mM glucose, and 0.1% BSA) and stimu-
lated at 37 °Cwith DNP conjugated-human serum albumin (HSA) (anti-
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Fig. 3. Pericentrosomal accumulation of ERK2 is phosphorylation-independent. (A) IgE-sens
riods. Cells were subsequently lysed and cell lysates were resolved by SDS-PAGE and immu
against anti-total ERK1/2. A representative blot is shown. The intensities of the bands w
Means ± SEM of 3 separate experiments are presented. *p b 0.03. (B) IgE sensitized RBL ce
incubated with 20 μMU0126 for 30 min. Cells were then activated with 50 ng/ml DNP-HSA
ﬁxed and labeled with rabbit polyclonal antibodies against ERK2 and mouse monoclonal
Cy5-conjugated donkey anti-mouse IgG. Cells were visualized by high-resolution laser con
the MTOC position. The circled area in the phase image depicts the position of ERK2.2.7. Determination of ERK1/2 activation
Cell extractswere prepared by the addition of lysis buffer A (150 mM
sucrose, 80 mM β-glycerophosphate, 2 mM EDTA, 2 mM EGTA, 2 mM
NaVO3, 10 mM sodium pyrophosphate [NaPPi], and 1% Triton X-100)pERK1
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itized RBL cells were activated with 50 ng/ml DNP-HSA (Ag) for the indicated time pe-
noblotted with anti-phospho-ERK1/2. Blots were reprobed with an antibody directed
ere quantiﬁed and relative (phosphorylated/total) pixel densities were calculated.
lls, grown on glass coverslips for 24 h, were serum starved for 1.5 h and subsequently
(Ag) for 5 min. The cells were gently permeabilized with 100 μg/ml digitonin for 5 min,
antibodies against α-tubulin followed by Cy3-conjugated donkey anti-rabbit IgG and
focal microscopy as described under Materials and methods. The arrowhead points to
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Fig. 4. Cell type speciﬁcity of pericentrosomal localization of ERK2. HeLa, Cos7 and HEK293 cells were serum starved for 2 h, and then either left untreated or stimulated with
100 ng/ml EGF for 5 min, as indicated. Cells were ﬁxed and labeled with rabbit polyclonal antibodies directed against ERK2 followed by Cy2-conjugated donkey anti-rabbit IgG
and Hoechst. Cells were visualized by laser confocal microscopy. Arrows point to the nuclear ERK2 and arrowheads to ERK2 located at the perinuclear region. Scale bar = 10 μm.
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2075A.B. Bar-Gill et al. / Biochimica et Biophysica Acta 1833 (2013) 2070–2082and resolved by 10% SDS PAGE under reducing conditions. Gels were
transferred to nitrocellulose membranes and probed overnight at 4 °C
with monoclonal antibodies directed against the active phosphorylated
forms of p44/p42 ERK1/2 (1/20,000 dilution).
2.8. Construction of GST fusion proteins
GST-PI4Kβ-Frag1, GST-PI4Kβ-Frag2 and GST-PI4Kβ-Frag3 were
constructed by PCR. GST-PI4Kβ-Frag1 was constructed using the sense
primer 5′ATCGGATCCATGGGAGATACAGTAGT3′ and the antisense
primer 5′CCAAGAATTCTCACCCCATCTCATCTTC3′ using GST-PI4Kβ full
length construct as template. GST-PI4Kβ-Frag2 was prepared similarly
using the same sense primer and the antisense primer 5′CCAAGAA
TTCTCAGGGTGCCTCTGCTAGAGACT3′. GST-PI4Kβ-Frag3 was prepared
using the sense primer 5′ATCGGATCCGGGAATAATGGG3′ and the
same antisense primer used to clone GST-PI4Kβ-Frag2. The PCR prod-
uctswere digested by EcoRI/BamH1 and subcloned into the pGEX2T vec-
tor. Fusion proteins were induced in BL21 cells by 1 mM IPTG at 37 °C
for 3 h and immobilized on Glutathione-Sepharose beads. GST-ERK1
and GST-ERK2 were previously described [21].
2.9. Western blot analysis
Samples of cell extracts (normalized according to protein content
or cell number) were separated by SDS-PAGE using 10–12% poly-
acrylamide gels and electrophoretically transferred to nitrocellulose
membranes. Blots were blocked for 1 h in Tris-buffered saline/Tween
20 (10 mM Tris–HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20)
containing 5% skim-milk or 2% bovine serum albumin (BSA) followed
by overnight incubation at 4 °C with the desired primary antibodies.
Blots were washed three times and incubated for 1 h at room tempera-
turewith HRP-conjugated secondary antibodies. Immunoreactive bands
were visualized by the enhanced chemiluminescence according to stan-
dard procedures.
2.10. Pull down experiments with GST fusion proteins
GST, GST-PI4Kβ, GST-PI4Kβ-Frag1, GST-PI4Kβ-Frag2, GST-PI4Kβ-
Frag3, GST-ERK1 or GST-ERK2 (20 μg) was immobilized on Glutathione-
Sepharose beads, incubated for 4 h at 4 °C with RBL cell lysates
(500 μg), and suspended in buffer B comprising 50 mM Hepes, pH 7.4,
150 mMNaCl, 1 mMMgCl2, 1% Triton X-100, 1 mM PMSF and a cocktail
of protease inhibitors. At the end of the incubation period, beads were
sedimented by centrifugation at 5000 g for 5 min at 4 °C, and washed 4
times with the same lysis buffer. Beads were then suspended in Laemmli
sample buffer, boiled for 10 min, resolved by 10% SDS-PAGE under reduc-
ing conditions, and transferred into nitrocellulose membranes for West-
ern blot analysis with the appropriate antibodies. Immunoblotting was
performed as described above.
2.11. Immunoﬂuorescence microscopy
RBL cells (5 × 104 cells/ml) were grown on 12-mm round glass
cover slips. After incubation for 18 h at 37 °C, the medium was aspi-
rated, and the adherent cells were washed three times with cold
phosphate-buffered saline (PBS). Cells were subsequently ﬁxed for
30 min in 4% paraformaldehyde and permeabilized for additional
30 min by a permeabilization solution (0.1% Triton, 5% fetal calf serum
[FCS], and 2% BSA in PBS). To stain the active ERK1/2 cellswere activated
as described above, ﬁxed and permeabilized in lysis buffer A. To allow
cytosol leakage, cells were treated with 100 μg/ml digitonin for 5 min
before ﬁxation and permeabilization. Cells were subsequently incubat-
ed for 1 h at room temperature with the primary antibodies, washed
three times, and incubated for 1 h with the appropriate secondary anti-
body. Cover slips were subsequently washed ﬁve times and mounted
with Gel Mount mountingmedium (Biomeda, Foster City, CA). Sampleswere analyzed using a Zeiss LSM 510 laser confocal microscope (Carl
Zeiss, Oberkochen, Germany) or Leica TCS SP5 II high-resolution confo-
cal microscope (Leica Microsystems, Wetzlar, Germany) using a 63 oil/
1.4 NA objective.
2.12. Presentation of data
The results presented are representative of at least three separate
experiments. Statistical analysis was performed using students' t test
with p value speciﬁcally described in each ﬁgure.
3. Results
3.1. ERK1 and ERK2 acquire distinct localizations in FcεRI-triggered
mast cells
In our previous study, where we ﬁrst identiﬁed the perinuclear ac-
cumulation of ERK in activated RBL cells, our mast cell model [3], we
used an antibody that recognizes both ERK1 and ERK2 (herein re-
ferred to as ERK1/2). To begin deciphering the mechanisms underly-
ing ERK translocation, we sought to monitor the intracellular routes
of each of the separate isoforms by using isoform speciﬁc antibodies.
First we conﬁrmed the speciﬁcity of the antibodies by Western blot
analysis of RBL cell lysates. Indeed, this analysis demonstrated that
the anti-ERK1 antibodies bound speciﬁcally to the p44 isoform, but
could also detect a higher molecular mass protein, of lower abun-
dance, that most likely corresponds to the ERK1b isoform (Fig. 1),
which we have previously identiﬁed [22]. The anti-ERK2 antibodies
bound speciﬁcally to the p42 isoform (Fig. 1). Therefore, these results
conﬁrmed that these antibodies could be used to study separately
ERK1 and ERK2. Expectedly, anti-ERK1/2 antibodies recognized both
the ERK1 and ERK2 isoforms (Fig. 1). Next, we used these isoform-
speciﬁc antibodies to analyze the intracellular locations of ERK1 and
ERK2 in resting and FcεRI-triggered cells. In resting cells, both ERK1
and ERK2 displayed a diffuse cytosolic staining (Fig. 2A). Upon cell
trigger, by the addition of an antigen (DNP-HSA) to IgE sensitized
cells, ERK1 translocated to the nucleus as expected (Fig. 2A). How-
ever, in sharp contrast, nuclear concentration of ERK2 was by far
less profound suggesting that this isoform may take a different
route (Fig. 2A). To substantiate further this notion and characterize
more precisely the route of trafﬁcking of ERK2 in triggered cells, we
repeated the separate staining of the ERK isoforms in cells that were
permeabilized with digitonin to allow leakage of the cytosol. This pro-
cedure, which enables unmasking of intracellular organelles, such as
the Golgi apparatus, from the cytosol [3,23], allowed us previously
to identify ERK localization at the ERC [3]. Strikingly, under these con-
ditions, ERK1 staining was completely lost, whereas ERK2 clearly
resisted the permeabilization by digitonin, suggesting its selective
localization in a digitonin resistant compartment (Fig. 2A). To further
characterize this compartment as well as the route of ERK2 trafﬁck-
ing, we co-stained the cells with an antibody directed against
α-tubulin that allowed us to visualize both the MTOC and the micro-
tubule network. This analysis demonstrated that in resting cells ERK2
localized to a pericentrosomal region near the MTOC (Fig. 2B). Fol-
lowing cell stimulation for 5 min, the amount of ERK2 that resisted
digitonin permeabilization has increased and it increased even fur-
ther at 30 min post cell stimulation, encompassing both the MTOC
and an area near the MTOC (Fig. 2B). This ﬁnding is consistent with
our previous observations, where the accumulation of ERK1/2 at the
ERC increased with the time of cell stimulation [3]. Quantitative anal-
ysis demonstrated that 80–90% of the α-tubulin, which resides at the
MTOC, colocalized with ERK2 in both resting and triggered cells,
suggesting that ERK2 co-localizes with the MTOC to the same extent
regardless of the cell's activation state. In contrast, only 50 and 30%
of digitonin resistant ERK2 colocalized with the MTOC at 5 and
30 min of antigen trigger, as opposed to 80% in resting cells, despite
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Fig. 6. PI4Kβ can pull down ERK from RBL cell lysates. (A) IgE sensitized cells were grown on glass cover slips for 24 h. The cells were then activated with 50 ng/ml DNP-HSA (Ag) as
described under Materials and methods for the indicated time periods, ﬁxed and labeled with rabbit polyclonal anti-PI4Kβ antibody followed by Cy2-conjugated donkey anti-rabbit
IgG. Cells were visualized by laser confocal microscopy. Scale bar = 10 μm. (B) Lysates derived from either untreated or activated RBL cells (500 μg) were subjected to pull-down assays
as described under Materials and methods with either GST, or full length GST-PI4Kβ. Bound proteins were resolved by SDS-PAGE and immunoblotted with antibodies directed against
ERK1/2. A representative blot is shown. The intensities of the bands were quantiﬁed and relative (ERK/protein stain) pixel densities were calculated and normalized to GST binding.
The numbers above the blot correspond to means of the results from 3 different experiments.
2077A.B. Bar-Gill et al. / Biochimica et Biophysica Acta 1833 (2013) 2070–2082the increment in ERK2 perinuclear accumulation. Therefore it is
evident that while a fraction of ERK2 remained associated with the
MTOC, cell triggering resulted in the recruitment of cytosolic ERK2
to an area near the MTOC. Indeed, close inspection of high-
resolution confocal images and 3D reconstructed image stacks of
ERK2 location following 30 min of cell activation revealed that ERK2
resided at a pericentrosomal-tubule-vesicular structure (Fig. 2B, D),
reminiscent of the ERC [24]. Moreover, ERK2 was also spotted in
the midbody of mitotic cells (Fig. 2E), consistent with the well-
established role of the ERC in cytokinesis [25]. Notably, after activa-
tion, α-tubulin immunostaining distributed between tubules that
originated from the MTOC and peripheral dots (Fig. 2B–D). However,
since staining forα-tubulin was performed under conditions aimed at
preserving ERK phosphorylation (i.e. 4 °C), that are non-optimal for
the preservation of dynamic microtubules, these dots might reﬂect
aggregates of tubulin dimers. Such increased sensitivity of the micro-
tubules in triggered cells is consistent with previous observations that
documented dynamic alterations in the microtubules in response to
cell triggering [26].
Monitoring the kinetics of ERK1 and ERK2 phosphorylation in
response to the antigen trigger indicated that phosphorylation of both
isoforms peaked between 5 and 10 min and declined thereafter
(Fig. 3A). This observation strongly suggested that the pericentrosomal
accumulation of ERK2 was uncoupled from its phosphorylation. To testFig. 5. NCS-1 enhances the pericentrosomal localization of ERK2. (A) IgE sensitized RBL cell
and either left untreated or activated with 50 ng/ml DNP-HSA (Ag) for 5 min as described u
itonin and ﬁxed with 4% PFA. Cells were labeled with rabbit polyclonal antibodies directed a
Cells were visualized by laser confocal microscopy. Scale bar = 10 μm. (B) The region of inte
area near the nucleus (i.e. 1 μm from the nucleus) that is positively stained for ERK and doe
ROI was quantiﬁed using the Matlab software. Means ± SEM of 3 separate experiments arthis notion directly, we tested the inﬂuence of the MEK inhibitor,
U0126, which is known to inhibit phosphorylation of both ERK1 and
ERK2 [27], on this process. Indeed, under the same conditions that
U0126had completely abolished ERK1/2phosphorylation, this inhibitor
failed to affect the pericentrosomal accumulation of ERK2 (Fig. 3B).
Notably, quantitative analyses of ERK1/2 phosphorylation in FcεRI-
activated cells revealed that ERK2was phosphorylated to a lower extent
than ERK1 or ERK1b despite its higher expression (Fig. 3A). Since phos-
phorylated ERK2was reported to penetrate the nucleus rapidly [28–33],
reduced phosphorylation of ERK2 is consistentwith its pericentrosomal
accumulation.3.2. Perinuclear accumulation of ERK2 is cell type speciﬁc
Because selective pericentrosomal retention of ERK2 was not
reported before, we next asked whether it was speciﬁc for mast cells.
To this end, we analyzed ERK1 and ERK2 distribution in three additional
cell lines under resting and activated conditions. We could not detect
any perinuclear accumulation of ERK2 in resting or EGF activated HeLa
or Cos7 cells (Fig. 4). Instead, nuclear translocation was clearly evident
following EGF treatment (Fig. 4). However, in EGF activated HEK293
cells, ERK2 clearly distributed between the nucleus and a perinuclear lo-
cation (Fig. 4). Therefore, perinuclear accumulation of ERK2 in activateds or RBL cells stably transfected with NCS-1 (OE-NCS-1) were grown on glass coverslip
nder Materials and methods. The cells were gently permeabilized with 100 μg/ml dig-
gainst ERK2 or ERK1 followed by Cy3-conjugated donkey anti-rabbit IgG and Hoechst.
rest (ROI), i.e. the pericentrosomal area in resting or activated cells, was deﬁned as the
s not contain any nuclear staining. The intensity of ﬂuorescence of ERK1/ERK2 in each
e presented. *p b 0.03.
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with 50 ng/ml DNP-HSA for 5 min. Cells were either ﬁxed or ﬁrst permeabilized with
100 μg/ml digitonin for 5 min prior to ﬁxation, as indicated. Cells were then labeled
with rabbit polyclonal antibodies against ERK2 and with mouse monoclonal antibodies
againstα-tubulin followedbyCy3-conjugateddonkey anti-rabbit IgG andCy5-conjugated
donkey anti-mouse IgG. Cells were visualized by high-resolution laser confocal microsco-
py as described under Materials and methods. Arrowheads point to the MTOC and the
arrow points to nuclear ERK2.
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than the mast cells.
3.3. NCS-1 enhances perinuclear accumulation of ERK2
NCS-1 (also termed frequenin) is a member of the calmodulin
superfamily of EF-hand Ca2+ sensing proteins, which has been implicat-
ed in numerous cellular functions, including regulation of secretion and
membrane trafﬁc, control of voltage gated Ca2+ channels, activation of
PI4Kβ and synaptic plasticity (reviewed in [34]). Previously, we showed
that NCS-1 potentiates mast cell exocytosis by stimulating PI4Kβ and
increasing the pool of PI(4,5)P2 that is needed for FcεRI-triggered hydro-
lysis [35]. We have further shown that NCS-1 also enhances perinuclear
accumulation of ERK [3]. Therefore, we next analyzed the impact of
NCS-1 on the localizations of each of the ERK isoforms in resting and
activated cells. The results are presented in Fig. 5, which shows that in
RBL cells that stably overexpress NCS-1, the amount of perinuclear
ERK2 in resting cells is 1.7 fold higher than in control cells. In contrast,
no change was recorded in ERK1 that remained cytosolic in resting
cells. The impact of NCS-1 was even more profound in FcεRI-triggered
cells, where a 2.2 fold increase in perinuclear ERK2 was determined in
NCS-1-overexpressing cells, as compared with control cells (Fig. 5A
and B). This effect was again speciﬁc for ERK2, while ERK1 retained its
cytosolic location in restingNCS-1 overexpressing cells and translocated
to the nucleus following their FcεRI-mediated activation. Notably, con-
sistent with our previous results that documented increased phosphor-
ylation and nuclear translocation of ERK in NCS-1 overexpressing cells
[3], phosphorylation and nuclear translocation of ERK1 seemed to in-
crease in the NCS-1 overexpressing cells (Fig. 5A).
3.4. ERK2 interacts with PI4Kβ in activated cells
Because the pericentrosomal accumulation of ERK2 was indepen-
dent of this kinase phosphorylation and yet stimulated by an external
trigger, we postulated that ERK2 may bind to a factor that associates
with the ERC in an antigen dependent fashion. An attractive candidate
to fulﬁll such role is PI4Kβ, which is a downstream target of NCS-1
[36–38] and in addition is a binding partner of the ERC localized Rab11
small GTPase [39]. To test this possibility, we examined the cellular lo-
calization of PI4Kβ in resting and activated RBL cells. Indeed, the results
obtained supported such premise showing a perinuclear accumulation
of PI4Kβ in response to an antigen trigger (Fig. 6A). Therefore, we next
assessed the ability of GST-PI4Kβ to pull down ERK2. Indeed, under
these in-vitro conditions, GST-PI4Kβ was able to pull down both ERK1
and ERK2 from RBL cell lysates (Fig. 6B). This binding did not require
prior cell activation, therefore suggesting that trigger-dependent modi-
ﬁcations were not required to allow this interaction (Fig. 6B).
To gain insight into the binding site of PI4Kβ, we also analyzed the
ERK2 pull down efﬁcacy of PI4Kβ N-terminal regions, i.e. amino acids
1 to 105 (Frag1), 1 to 73 (Frag2) and 22 to 73 (Frag3), fused to GST
(Fig. 7A) and found that both Frag1 and Frag2, but not Frag3, were
able to pull down ERK2, though they were by 2 fold less efﬁcient than
the full-length recombinant protein (Fig. 7B). Therefore these results
implicated the ﬁrst 22 amino acids of the N-terminus of PI4Kβ in medi-
ating ERK2 binding, though additional motifs or conformational con-
straints seem to dictate the afﬁnity of interaction.
3.5. ERK2 interacts with γ-tubulin
The MTOC serves not only as a docking site for perinuclear organ-
elles such as the ERC [40], but also as a site of signaling complex assem-
bly. Speciﬁcally, nonreceptor protein tyrosine kinases such as Src and
Fyn [41], as well as PI3K [42], were shown to interact with γ-tubulin.
Furthermore, previous analyses have suggested that one-third of the
total ERK is associated with the microtubule cytoskeleton in NIH 3T3
mouse ﬁbroblasts [43]. These ﬁndings together with the colocalizationof ERK2 and tubulin at the MTOC prompted us to investigate whether
ERK2 might also form a complex with γ-tubulin. To this end, we exam-
ined the ability of GST-ERK2 or GST-ERK1 to pull down α or γ-tubulin
from RBL cell lysates. These experiments demonstrated that ERK2 was
able to pull down both γ and α-tubulin from RBL cell lysates though
its afﬁnity for γ-tubulin was considerably higher (Fig. 8A). GST-ERK1
was also able to pull down tubulin, however its efﬁcacy was 3 fold
lower (Fig. 8A). These results have therefore suggested that γ-tubulin
interacts preferably with ERK2.
Ag 
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0
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α-tubulin
Fig. 8 (continued).
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centrosomal localization of the ERC, but leaves the MTOC intact ([44]
and Fig. 8B). Therefore, we next analyzed ERK2 localization in nocodazole
treated cells to distinguish between MTOC and ERC bound ERK2. Same
as in its absence, also in nocodazole treated cells, a small fraction of
ERK2 was retained in digitonin-permeabilized cells and colocalized with
the MTOC, suggesting its direct binding to the MTOC, presumably by
interacting with γ-tubulin (Fig. 8B). Strikingly, visualizing ERK2 location
in nocodazole treated and antigen-activated cells revealed that ERK2
acquired a nuclear location (Fig. 8B). Accordingly, digitonin perme-
abilization of nocodazole treated and antigen activated cells resulted in
complete leakage of ERK2 (Fig. 8B). In nocodazole treated cells, triggered
for 30 min, ERK2 displayed a diffuse cytosolic staining thatwas complete-
ly lost in digitoninpermeabilized cells (not shown). Therefore, collectively
these results demonstrated that disruptionof themicrotubule networkbynocodazole prevents the association of ERK2 with the ERC in activated
cells.
4. Discussion
Previously, we have demonstrated that the MAP kinases ERK1/2
acquire perinuclear localization and colocalize with Rab11 and internal-
ized transferrin in FcεRI activated cells [3]. In this work we have studied
separately the spatiotemporal characteristics of the ERK isoforms ERK1
and ERK2 in the activated mast cells and demonstrate for the ﬁrst time
their clear segregation. ERK1, which is also highly phosphorylated in
the triggered cells, translocates to the nucleus. In contrast, in response
to cell activation ERK2 accumulates at a pericentrosomal region that
we previously identiﬁed as the ERC [3]. The pericentrosomal accumula-
tion of ERK2 increases with time of activation despite the concurrent
2081A.B. Bar-Gill et al. / Biochimica et Biophysica Acta 1833 (2013) 2070–2082decline in ERK2 phosphorylation. Accordingly, consistent with the
notion that phosphorylation is dispensable for the pericentrosomal
targeting of ERK2, the MEK inhibitor U0126 that abrogates completely
ERK phosphorylation does not prevent this process. Strikingly, disrup-
tion of the microtubule network by nocodazole prevents completely
ERK2 association with the ERC and results in its increased translocation
to the nucleus. Indeed, the results of our pull down assays demonstrate a
phosphorylation independent interaction between ERK2 and γ-tubulin.
This interaction is rather speciﬁc for ERK2, as demonstrated by the con-
siderably less efﬁcient pull down of γ-tubulin by GST-ERK1. ERK2
colocalizes with the MTOC in resting cells, both in the absence or pres-
ence of nocodazole, but it associates with the ERC in a trigger and
microtubule-dependent manner. Therefore, our results are compatible
with a model, whereby the association with the MTOC separates ERK2
from ERK1 and restricts its trigger-dependent phosphorylation, thereby
withholding the nuclear translocation of ERK2. Subsequent binding of
the MTOC-bound ERK2 to an ERC-bound factor then facilitates its accu-
mulation at the ERC. Indeed, dispersion of the ERC by nocodazole pre-
vents MTOC-bound ERK2 from interacting with its ERC docking site,
therefore enabling its alternative route, hence, nuclear accumulation.
In thismodel, associationwith theMTOC places ERK2 at the correct spa-
tiotemporal position to interact with the ERC and is therefore a crucial
step in the segregation of ERK2 from ERK1. Based upon our results,
PI4Kβ is an attractive candidate to serve the role of the ERC docking
site for ERK2. First, we show that PI4Kβ pulls down ERK2 from RBL cell
lysates; second, PI4Kβ was shown to interact with the ERC resident
Rab11 [39]; third, we showhere that PI4Kβ accumulates in a perinuclear
region in a trigger-dependent fashion,which could account for the trigger
dependency of ERK2 accumulation at the ERC; ﬁnally, NCS-1, which is an
upstream regulator of PI4Kβ [36–38], increases the pericentrosomal ac-
cumulation of ERK2. Thus, although both ERK1 and ERK2 could pull
down PI4Kβ from RBL cell lysates in our in vitro assays, according to
our model, only ERK2 that binds to the MTOC and whose reduced phos-
phorylation restricts its nuclear translocation would interact with PI4Kβ
in vivo and consequently accumulate at the ERC.
We have mapped the site of interaction between ERK2 and PI4Kβ
to the ﬁrst 73 N-terminal amino acids of PI4Kβ, where the ﬁrst 22
amino acids seem to be essential. This site is distinct from the non-
catalytically C-terminus domain of PI4Kβ, which mediates its association
with Rab11 [39]. Therefore PI4Kβ may simultaneously bind to both
Rab11 and ERK2. Interestingly, we could not detect any perinuclear accu-
mulation of ERK2 in HeLa or Cos7 cells. However, such accumulationwas
observed in HEK293 upon their stimulation with EGF. Hence, while the
molecular basis of this cell type speciﬁc pericentrosomal translocation is
presently unknown, it may be related to the cellular expression or func-
tion of NCS-1. Notably, our results demonstrating that the interaction be-
tween ERK2 and PI4Kβ does not require ERK2 phosphorylation extend
the repertoire of proteins that have been previously shown to interact
with ERK2 independently of its phosphorylation state (reviewed in [45]).
Taken together, our results suggest a novel regulatory axis consisting
of NCS-1, PI4Kβ, γ-tubulin and ERK2 thatmay either negatively regulate
mast cell functions by acting as scavenger of ERK2 that restricts its phos-
phorylation and nuclear translocation, or it may segregate ERK2 for the
assignment of unique cellular functions. For example, ERK2 may be
involved in the regulation of recycling [3] or ERC-dependent functions,
such as cytokinesis that is regulated byRab11 andPI4Κβ [25]. Consistent
with the latter notion is the detection of ERK2 at the microtubule
midbody. Hence, while more studies are required to explore these
possibilities, it is tempting to speculate that ERK2 may coordinate
mast cell degranulation with cytokinesis. Intriguingly, deletions in
chromosome 22q11.2 that encompasses the ERK2 gene are signiﬁ-
cantly associated with both eczema and asthma [46], suggesting
the loss of a negative regulator of mast cell functions. This chromo-
somal deletion is also associated with impaired long-term memory
[47] and schizophrenia [48], pathological conditions in which NCS-1
is implicated [49].Disclosure
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